Syros Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for Syros Pharmaceuticals Inc are displayed. Comprehensive ESG analysis of Syros Pharmaceuticals Inc are reached by signing up for free. Scroll down to the bottom of this webpage for potential risks for Syros Pharmaceuticals Inc based on industry, geography and size.
Syros Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 6.0, social score of 8.0 and governance score of 8.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Syros Pharmaceuticals Inc | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Syros Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Syros Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Syros Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Syros Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Syros Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Syros Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Syros Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Syros Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.